David Buchebner, MD, PhD, is a physician specialised in endocrinology. He completed his doctoral studies in osteoporosis research at Lund University and holds a medical degree from the Medical University of Vienna.
His main scientific interests include osteoporosis, vitamin D, overweight and obesity, and the internal medicine aspects of endocrinology. David has combined many years of clinical work with research-driven development at Hallands Hospital Halmstad and within Region Halland.
Since 2024, he has served as Quality Assurance Manager at Yazen Health, where his expertise in endocrinology and metabolic disease supports the development of evidence-based care.
More articles by
David Buchebner
.webp)
High Adherence to GLP-1 Receptor Agonists: 18-Month Outcomes from the Yazen Model
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Heading 6
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
Block quote
Ordered list
- Item 1
- Item 2
- Item 3
Unordered list
- Item A
- Item B
- Item C
Bold text
Emphasis
Superscript
Subscript

Yazen Health AB operates as a registered healthcare provider under the General Data Protection Regulation (GDPR), the Swedish Health and Medical Care Act, Patient Data Act, and the Patient Security Act. Our proprietary systems, including the patient app and electronic medical record (EMR) system, are officially registered with the Swedish Health and Social Care Inspectorate (IVO).



